HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MULTAQ safely and effectively. See full prescribing information for MULTAQ.
17.2 Medication Guide . Medication Guide MULTAQ (MUL-tak) (dronedarone) Tablets . Read this Medication Guide before you start taking MULTAQ and each time you get a
Medication Guide Rx Only MULTAQ (MUL-tak) (dronedarone) Tablets Read this Medication Guide before you start taking MULTAQ and each time you get a refill.
Medication Guide Rx Only MULTAQ ® (MUL-tak) (dronedarone) Tablets Read this Medication Guide before you start taking MULTAQ and each time you geta refill.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MULTAQ safely and effectively. See full prescribing information for MULTAQ.
PRESS RELEASE 1/2 European Medicines Agency (EMA) confirms positive benefit-risk balance for Multaq ® - European Prescribing Information Updated to Ensure Multaq ® Use in Appropriate Paroxysmal and Persistent AF Patients - Paris, France - September 22, 2011 - Sanofi (EURONEXT: SAN and NYSE ...
AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION MULTAQ® (DRONEDARONE) Briefing Document Advisory Committee Meeting of the Cardiovascular and Renal Drugs Division of the US Food and Drug Administration March 18, 2009 Date: 12-Feb-2009 Version: FINAL
Questions and answers on the review of Multaq (dronedarone) Questions and answers on Multaq Article 20
1 of 4 MULTAQ Patient Support Program Phone 1-888-968-5827 Fax 1-866-910-9024 APPLICATION INSTRUCTION GUIDE To ensure that you maximize the full range of services for the MULTAQ Patient Support Program, we have
SR 33589 / MULTAQ (DRONEDARONE) 09 June 2009 Proposed Risk Evaluation and Mitigation Strategy (REMS) Version 7.0 Final TABLE OF CONTENTS I. GOALS ..... 3 II.